ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth

NAV 35.84(-0.99%)
Apr 01, 2025
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth
AUM
₹4,611 Cr
Expense (%)
1.94
Turnover (%)
95.00
Benchmark
BSE Health Care - TRI
Asset Quality
Large, Green
Differs from benchmark (%)
95.24

Decision Maker

1. Right Fund

Performance
Quality

2. Right Time

Benchmark
Debt Fund
8%
Likely Future 5 Year CAGR.

3. Right Allocation

Will this Fund help diversify your portfolio?

3Yr Rolling Returns(%)

Benchmark# : NIFTY 500

CAGR

9 Year5 Year3 Year1 Year
Benchmark# BM# Returns(%)
-16.5711.59-0.7
Fund Returns(%)
-26.4921.6412.22
Implied  Investor Returns(%) IR
-24.7124.7221.31
                                                                                                                                                            Benchmark# is NIFTY 500

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Review : 02 Apr 2025

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care with an 4,611(Cr) AUM. It is Open Ended scheme launched on 13 Jul 2018. Currently, Dharmesh Kakkad as the manager managing the fund. Benchmark of the scheme is BSE Health Care - TRI.

1. How has the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Performed in the past? 22

  • On a 3-year rolling returns basis It has not outperformed the Benchmark consistently..
  • The fund has delivered a 3, 5 and 9 year average rolling returns of 22.31%, 25.91%, and 0.00% with a standard deviation of 3.39%, 4.76%, and 0.00% respectively.
  • It has demonstrated CAGR of 21.64%, 26.49%, and 0% over 3, 5 and 9 years.
  • The Average 3, 5 and 9 year rolling Alpha is 3.97%, 8.87%, and 0%.
  • For last 5 years, Investors have earned less returns than the Fund. This may indicate that Investors in the fund were not aligned to the investing process followed by the fund.

2. How is the Quality of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund? Q

Fund's Portfolio Quality is Very Good. It has a large proportion of Green Stocks.
  • Portfolio Composition

    The fund is 99% in equity and hold 43 number of stocks. The Top 3 stocks are Dr. Reddys Lab, Cipla and Sun Pharma Inds. and account for 32% of its portfolio. Top 5 and 10 stocks of fund account for 44% and 62% of fund’s portfolio respectively. Top three sectors of funds are Healthcare, Miscellaneous and Chemicals accounting for 97% of the total portfolio.
  • 3. Should you SIP in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund? 22 Q

    • You should look for a fund with better more consistent performance track record.
    • Fund's returns are more likely to be different than its benchmark NIFTY 500 returns, as Fund’s portfolio is significantly different.
    • You need to look at the other funds in your portfolio and ensure this fund helps diversify your portfolio meaningfully.
    • Before investing a large lumpsum amount in a fund you need to assess its Upside Potential. You can contact us for advice.

    4. What are the Risks in the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund?

    • ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is likely to perform reasonably well in both a rising and falling markets.
    • The Fund has fallen harder, but not recovered faster than its Benchmark.

    Underlying Asset Quality & Valuation

    Underlying Asset Quality Valuation(%)
    Underlying Asset Valuation (%)

    Peer Comparison on returns

    Upside and Downside Capture Ratio

    1 Year3 Year5 Year9 Year
    Upside %
    139115101-
    Downside %
    54624250

    Statistical Measure*

    Mean Std Dev Sharpe Sortino Beta Alpha
    Fund
    0.03%0.880.010.020.57-4.86%
    Benchmark#
    0.08%0.900.070.120.57-
    *Based on daily returns for past 1 year.

    Mean and Standard Deviation

    Average Rolling Return Standard Deviation
    1 Year 3 Year5 Year9 Year1 Year3 Year5 Year9 Year
    Fund
    30.3522.3125.910.0028.793.394.760.00
    Benchmark#
    19.8318.3417.030.0022.504.192.640.00
    Drawdown and Recovery Period

    No Data Found

    Top 10 Holdings

    Company (Q)Sector% Assets
    Healthcare13.21
    Healthcare9.55
    Healthcare8.94
    Healthcare6.78
    Healthcare5.15
    Healthcare4.73
    Healthcare4.49
    Healthcare3.52
    Healthcare3.27
    Healthcare2.85

    Fund Overview ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth

    Launch Date
    13 Jul 2018
    Benchmark
    BSE Health Care - TRI
    Performance comparison Benchmark#
    NIFTY 500
    Riskometer
    Very High
    Turnover
    95%
    Type
    Open ended scheme
    Return Since Launch
    21.04%
    Min. Investment
    5000.00
    Min. Additional investment Min. Add. inv.
    1000.00
    Min. SIP
    100.00
    Min. Cheques
    6
    Min. Withdrawal
    500.00
    Exit Load
    1.00%
    Remark
    1% on or before 15D, Nil after 15D
    PortfolioCompare

    FAQ : ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth

    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth has delivered CAGR and average rolling returns as follows :

    1 Year 3 Year 5 Year 9 Year
    CAGR(%) 12.22 21.64 26.49 N/A
    Average Rolling Returns(%) 30.35 22.31 25.91 N/A

    The Current NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is ₹35.84.

    You should look for a fund with better more consistent performance track record. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.

    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth fund’s expense ratio is 1.94%

    The process for redemption is

    • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
    • You will get information about the redemption and the NAV at which redeemed.
    • The amount will be deposited in the designated bank account.

    The AUM of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is currently ₹4,611 Crores.

    The Top three stocks are Sun Pharma Inds., Cipla and Dr. Reddys Lab and account for 32% of its portfolio. Top 5 and 10 stocks of fund account for 44% and 62% of fund’s portfolio respectively.

    Top three sectors of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth fund are Healthcare, Miscellaneous and Chemicals accounting for 97% of the total portfolio.

    Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

    The category of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth Fund is Equity - Sectoral Fund - Pharma & Health Care.

    Dharmesh Kakkad manages the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth Fund.

    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth current PE ratio is 37.19 and PB ratio is 5.11

    The asset allocation of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is Stocks : 99.04%, Debt : 0.96% and Gold : 0%

    The minimum SIP amount for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is ₹100.00 and minimum lumpsum is ₹5000.00

    The exit load for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is 1% on or before 15 days, Nil after 15 days

    © 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
    Please wait your portfolio is updating...